Search

You searched for "lasers"

649 results found

Penile cancer

1 July 2021 | | URO - Urologic Oncology
Case 1 A 67-year-old man presents with a worsening red patch over the past three months. It looks velvety in some areas. What is the most likely diagnosis? What are the risk factors? How do you classify this condition? How...

Demanding cases or nightmares in uro-oncology? May/Jun 2022

3 May 2022 | | URO - Urologic Oncology
Delayed diagnosis of testicular cancer Testicular cancer is considered rare in the general population but is the most common cancer affecting males between 24 and 49 years. The diagnosis of testicular cancer depends on physical examination, ultrasound findings and tumour...

The scent of Ethiopia: a personal story – part 1

1 April 2016 | | URO - Andrology, URO - Basic Science Research, URO - Endourology & Stones, URO - Infection, URO - Functional / Reconstructive Urology, URO - Neurourology, URO - Paediatric Urology, URO - Technology, URO - Trauma & Emergency, URO - Urologic Oncology, URO - Uroradiology
Background The year was 2004; I had just moved to the UK as a young house officer and finished my observership programme at Great Ormond Street Hospital in London. I was inspired by greats like Patrick Duffy and Phillip Ransley,...
Journal of Clinical Urology front cover image.

Adjustable Transobturator Male System® as a novel treatment for men with stress urinary incontinence

2 July 2025 | | URO - Functional / Reconstructive Urology
Stress urinary incontinence (SUI) in men is a debilitating condition, often occurring after prostate cancer surgery, with an incidence ranging from 4% to 40%. Key predictors of SUI post-prostatectomy include age, body mass index (BMI), comorbidity index, lower urinary tract...

Demanding cases or nightmares in endourology? Nov/Dec 2017

1 November 2017 | | URO - Endourology & Stones
Case 1 A 78-year-old male was transferred from a referring hospital. He had a cystectomy and ileal conduit performed 15 years previously and had recently been admitted with a clinical diagnosis of an infected obstructed kidney. The referring hospital had...

Focal therapies in prostate cancer

1 November 2018 | | URO - Urologic Oncology, URO - Technology
The standard of care in the management of prostate cancer has, to date, always been to treat the whole gland. This has ranged from surveillance, surgical excision / prostatectomy or external beam radiotherapy / whole gland brachytherapy. With the evolution...

Redundant! Do urological surgeons have a future in treating urological cancers? RSM Urology Section Meeting

4 March 2024 | | URO - Urologic Oncology
December 2023 marked the latest RSM Urology Section event. Alongside the Winter Short Papers Prize presentations, the theme of the day was major urological cancers and the role of the urologist in patient management within the multidisciplinary team (MDT). We...

BURST @ BAUS25

17 July 2025
By Quentin Mak, Head of Secretariat; Aqua Asif, Head of Communications; Cameron Alexander, Co Vice-Chair; and Arjun Nathan, Co- Chair, BURST. BAUS is a cornerstone in the British Urological Researchers in Surgical Training (BURST) calendar. The conference offers BURST the...

The Prostate Cancer Foundation awards more than $6 million to promising young investigators to advance prostate cancer research

14 May 2025
The Prostate Cancer Foundation (PCF) announced that its 2024 Young Investigator Award programme has awarded a total of $6.3 million in funding to 30 promising next-generation researchers conducting innovative prostate cancer research. The PCF programme, now in its 27th year,...

Fertility 2026 - 19th Annual Fertility Conference is heading back to Edinburgh!

22 July 2025 | Urology News
Fertility 2026 is an industry event focused on Fertility and Reproductive Science, welcoming some of the worlds leading experts. We’re excited to announce that Fertility 2026 is heading back to the vibrant city of Edinburgh for the 19th Annual Fertility...

Recent advances in the management of castration resistant prostate cancer

1 November 2017 | | URO - Urologic Oncology
Castrate resistant prostate cancer (CRPC) is defined by disease progression despite androgen-deprivation therapy lowering testosterone to castrate levels. It may present as a rise in serum levels of prostate specific antigen (PSA), progression of pre-existing disease, or the appearance of...

An introduction to research governance

1 January 2017 | | URO - Andrology, URO - Basic Science Research, URO - Endourology & Stones, URO - Infection, URO - Functional / Reconstructive Urology, URO - Neurourology, URO - Paediatric Urology, URO - Trauma & Emergency, URO - Urologic Oncology, URO - Uroradiology, URO - Technology
Research is the process of acquiring new generalisable knowledge and should be fully integrated into healthcare work. There is a growing drive to encourage and further develop evidence-based practice in medicine so that staff and patients benefit from improved healthcare...